Scarica l'app Stockscreener
25.79
1.18%
0.31
Precedente Chiudi:
$25.48
Aprire:
$25.48
Volume 24 ore:
2.44M
Relative Volume:
0.43
Capitalizzazione di mercato:
$12.88B
Reddito:
$4.89B
Utile/perdita netta:
$-242.00M
Rapporto P/E:
-52.74
EPS:
-0.489
Flusso di cassa netto:
$315.00M
1 W Prestazione:
+0.94%
1M Prestazione:
+7.87%
6M Prestazione:
+3.49%
1 anno Prestazione:
+72.67%
Intervallo 1D:
$25.23
$25.95
Intervallo di 1 settimana:
$25.04
$26.37
Portata 52W:
$13.39
$27.72
Elanco Animal Health Inc Stock (ELAN) Company Profile
Nome
Elanco Animal Health Inc
Settore
Telefono
877-352-6261
Indirizzo
450 ELANCO CIRCLE, INDIANAPOLIS
Compare ELAN vs TAK, HLN, TEVA, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
25.78 | 12.56B | 4.89B | -242.00M | 315.00M | -0.489 |
TAK
Takeda Pharmaceutical Co Adr
|
16.95 | 55.02B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.875 | 43.69B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.36 | 36.10B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
74.11 | 31.95B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
529.30 | 26.36B | 3.17B | 1.29B | 1.01B | 27.09 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-15 | Iniziato | Citigroup | Buy |
| 2026-01-22 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-11-21 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | Aggiornamento | Argus | Hold → Buy |
| 2025-10-07 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2025-07-17 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | Iniziato | UBS | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Market Perform |
| 2024-09-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-19 | Iniziato | Jefferies | Buy |
| 2023-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-04-20 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Downgrade | Goldman | Buy → Sell |
| 2022-07-12 | Iniziato | Piper Sandler | Neutral |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-28 | Downgrade | Stifel | Buy → Hold |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-06-15 | Aggiornamento | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Iniziato | Stifel | Buy |
| 2021-03-22 | Downgrade | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Downgrade | Argus | Buy → Hold |
| 2020-11-09 | Downgrade | Barclays | Overweight → Underweight |
| 2020-08-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Ripresa | Credit Suisse | Neutral |
| 2020-08-04 | Ripresa | Goldman | Buy |
| 2020-07-27 | Downgrade | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-19 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Iniziato | Barclays | Overweight |
| 2019-08-26 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Neutral |
| 2019-03-18 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Ripresa | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Iniziato | William Blair | Mkt Perform |
| 2019-01-23 | Iniziato | UBS | Sell |
| 2019-01-15 | Iniziato | Argus | Buy |
| 2018-10-15 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Elanco Animal Health Inc Borsa (ELAN) Ultime notizie
Elanco Animal Health Incorporated Stock 12‑Month Price Target Raised to $30.23, Implies 19% Upside - TradingView
Elanco’s Credelio Quattro shows faster tick kill in study By Investing.com - Investing.com Canada
Elanco's Credelio Quattro Maintains 8-Hour Tick Kill Through Day 28 - Stock Titan
Elanco Animal Health Incorporated $ELAN Shares Sold by Bank of New York Mellon Corp - MarketBeat
Dimensional Fund Advisors LP Has $586.92 Million Stock Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
LLY4841184 Bond Profile — Key Metrics - TradingView
Jennison Associates LLC Purchases 494,216 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Principal Financial Group Inc. Grows Stock Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
472,814 Shares in Elanco Animal Health Incorporated $ELAN Purchased by Dorsey Wright & Associates - MarketBeat
Allspring Global Investments Holdings LLC Acquires New Shares in Elanco Animal Health Incorporated $ELAN - MarketBeat
KIN stock trades quietly as Kindred Biosciences acquisition leaves legacy metrics in focus - ad-hoc-news.de
Geneos Wealth Management Inc. Purchases 196,884 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Fifth Third Bancorp Grows Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Ends Apollo Government Relations Lobbying Deal - Legis1
Will Elanco Animal Health (ELAN) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Elanco Animal Health (NYSE: ELAN) awards CEO new deferred stock units - Stock Titan
Elanco Animal Health (NYSE: ELAN) awards CFO new deferred stock units - Stock Titan
Elanco Animal Health (NYSE: ELAN) awards deferred stock units to company officer - Stock Titan
Dimensional Fund Advisors reports 5.1% Elanco Animal Health (ELAN) stake - Stock Titan
Elanco Animal Health Incorporated (NYSE:ELAN) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
How Elanco Helped Puppies Fight Parvo - CSRwire
Form 4 Elanco Animal Health For: 9 July By Investing.com - Investing.com Nigeria
Elanco (NYSE: ELAN) CFO uses 15,336 shares to cover tax liability - Stock Titan
Elanco Confirms Date and Conference Call for Second Quarter 2026 Financial Results Announcement - GuruFocus
Elanco sets Aug. 5 call for second-quarter 2026 results - Stock Titan
Elanco to Launch Elanco Ventures with $25 Million Multi-Year Commitment to Accelerate Innovation in Animal Health - AOL.com
Integrated Advisors Network LLC Purchases New Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Strs Ohio Grows Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
SG Americas Securities LLC Reduces Stock Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elanco Animal Health - TMX Newsfile
NYSE: ELAN Lawsuit Alert: Investors who lost money with Elanco A - GuruFocus
Elanco Animal Health Inc (NYSE:ELAN) Technical Breakout Setup Scores 10/10 Technical Rating and 9/10 Setup Quality - ChartMill
Form 4 Elanco Animal Health For: 2 July By Investing.com - Investing.com Nigeria
Elanco (ELAN) executive awarded 25,620 stock options at $24.09 strike price - Stock Titan
Elanco (ELAN) director converts cash fees into 584 deferred stock units - Stock Titan
Form 4 Elanco Animal Health For: 30 June By Investing.com - Investing.com Canada
Elanco (NYSE: ELAN) executive receives new deferred stock unit award - Stock Titan
Elanco (ELAN) CEO Jeffrey Simmons receives 115 deferred stock units grant - Stock Titan
Elanco (NYSE: ELAN) CFO gets new deferred stock unit award - Stock Titan
Elanco Commits To Supporting US In Fight Against Screwworm - InkFreeNews.com
Is the Options Market Predicting a Spike in Elanco Animal Health Stock? - Yahoo Finance
Enterprise value to EBIT forward of Elanco Animal Health Incorporated – NYSE:ELAN - TradingView
Piper Sandler reiterates Elanco stock rating on defensive positioning By Investing.com - Investing.com Canada
Piper Sandler Maintains Elanco Animal Health(ELAN.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Price to sales forward of Elanco Animal Health, Inc. – MUN:5EA - TradingView
Price to earnings forward of Elanco Animal Health Incorporated – NYSE:ELAN - TradingView
Enterprise value to EBITDA forward of Elanco Animal Health Incorporated – NYSE:ELAN - TradingView
Enterprise value to revenue forward of Elanco Animal Health Incorporated – NYSE:ELAN - TradingView
Louisiana State Employees Retirement System Buys New Shares in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Inc (ELAN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Elanco working to manage parasitic fly’s arrival in U.S. - Indianapolis Business Journal
Elanco Animal Health Inc Azioni (ELAN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
8.24%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):